retatrutide phase 2 trial obesity just delivered the first top-line 3 results for a triple agonist in โ and the findings from TRIUMPH-4 are striking๐ Retatrutide, a TRIPLE agonist (GLP1,
Description
Learn how gum disease and diabetes are connected

The Gallup Poll found that overall, use of semaglutide medicines or liraglutides doubled from nearly 6% in the first quarter of 2024 to over 12% in Q2 + Q3 in 2025

Weight gain after a hysterectomy is common, but losing it is also possible

NewRhythm Akkermansia Muciniphila Probiotic is formulated with 100% natural ingredients and independently tested in 3rd party labs in the USA

Understanding how GLP-1 medications slow stomach function and increase GERD symptoms helps you make informed choices about your weight loss therapy

Bre Teamer chats with Dr
